Supplements to Support Candida DNA Microarray Facilities
Supplements to Support Candida DNA Microarray Facilities
批准号:
6314824
负责人:
Mira Edgerton
金额:
$25.0万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-03-01 至 2003-03-31
关键词:
Candida albicans antifungal agents calcium flux calorimetry candidiasis cell membrane chemical structure function chemical substitution circular dichroism drug screening /evaluation ergosterol glycoproteins high performance liquid chromatography histidine human tissue intermolecular interaction liposomes membrane activity membrane lipids protein purification protein structure function protoplast /spheroplast saliva synthetic peptide tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from the Investigator's abstract): Incidence of
oropharyngeal candidiasis has risen dramatically due to increased antibiotic
usage and longer survival of individuals with compromised immune systems
including patients on cancer chemotherapy, diabetics, AIDS patients and
premature infants. Relatively few antifungal drugs are available for clinical
treatment of oral or systemic candidiasis. Increased use of these agents to
treat candidiasis in late stage AIDS and cancer patients has resulted in
emergence of Candidal species with antifungal drug resistance, especially to
azole-based drugs. Histatins (Hsts) are small cationic polypeptides produced by
human major salivary glands. In vitro, Hst 5 is the most potent candidacidal
member of the family which kills 90% to 100% of Candida species at
physiological concentrations. Hsts' potent antifungal activity, lack of
toxicity to humans and ability to kill azole-resistant yeast strains underscore
the importance of detailed understanding of their mechanism of action.
Improvements in candidacidal function of Hsts and development of oral Hst
delivery systems also require information about the Hst-induced cascade of
cellular events leading to C. albicans death. Previous studies showed that Hst
mechanism of action is unique from other characterized antimycotic drugs in
that induction of lethal effect is through a novel pathway initiated by ATP
efflux from C. albicans cells, which occurs while the cell membrane is intact.
Studies are proposed to examine related properties of Hst-induced ATP release,
its cellular effects following Hst-induced ATP release leading to cell death,
requirements for intracellular transport of Hst for candidacidal activity and
examine potential involvement of cAMP, ABC transporters and purinergic
receptors in C. albicans response to Hst 5. These studies will contribute to
characterization of novel intracellular pathways utilized by Hst to cause yeast
cell death and lead to further understanding of the role of ATP efflux as a
cell regulatory or signaling process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells
-
批准号:10501899
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2022
-
负责人:Mira Edgerton
-
依托单位:
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells
-
批准号:10665797
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2022
-
负责人:Mira Edgerton
-
依托单位:
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3
-
批准号:10428637
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2021
-
负责人:Mira Edgerton
-
依托单位:
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3
-
批准号:10300121
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2021
-
负责人:Mira Edgerton
-
依托单位:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
-
批准号:2449485
-
项目类别:
-
资助金额:$8.36万
-
财政年份:1999
-
负责人:Mira Edgerton
-
依托单位:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
-
批准号:6164397
-
项目类别:
-
资助金额:$8.36万
-
财政年份:1999
-
负责人:Mira Edgerton
-
依托单位:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
-
批准号:6516337
-
项目类别:
-
资助金额:$8.36万
-
财政年份:1999
-
负责人:Mira Edgerton
-
依托单位:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
-
批准号:6362916
-
项目类别:
-
资助金额:$8.36万
-
财政年份:1999
-
负责人:Mira Edgerton
-
依托单位:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
-
批准号:6634566
-
项目类别:
-
资助金额:$8.36万
-
财政年份:1999
-
负责人:Mira Edgerton
-
依托单位:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
-
批准号:2015439
-
项目类别:
-
资助金额:$9.96万
-
财政年份:1997
-
负责人:Mira Edgerton
-
依托单位:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
-
批准号:2856658
-
项目类别:
-
资助金额:$10.56万
-
财政年份:1997
-
负责人:Mira Edgerton
-
依托单位:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
-
批准号:2634147
-
项目类别:
-
资助金额:$10.25万
-
财政年份:1997
-
负责人:Mira Edgerton
-
依托单位:
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS
-
批准号:2131541
-
项目类别:
-
资助金额:$10.3万
-
财政年份:1994
-
负责人:Mira Edgerton
-
依托单位:
Candidacidal Mechanisms of Salivary Histatins
-
批准号:8475448
-
项目类别:
-
资助金额:$36.16万
-
财政年份:1994
-
负责人:Mira Edgerton
-
依托单位:
Candidacidal Mechanisms of Salivary Histatins
-
批准号:7729518
-
项目类别:
-
资助金额:$34.59万
-
财政年份:1994
-
负责人:Mira Edgerton
-
依托单位:
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS
-
批准号:2131540
-
项目类别:
-
资助金额:$9.97万
-
财政年份:1994
-
负责人:Mira Edgerton
-
依托单位:
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS
-
批准号:6424725
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1994
-
负责人:Mira Edgerton
-
依托单位:
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS
-
批准号:6634626
-
项目类别:
-
资助金额:$19.64万
-
财政年份:1994
-
负责人:Mira Edgerton
-
依托单位:
Candidacidal Mechanisms of Salivary Histatins
-
批准号:7886772
-
项目类别:
-
资助金额:$38.05万
-
财政年份:1994
-
负责人:Mira Edgerton
-
依托单位:
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS
-
批准号:7425420
-
项目类别:
-
资助金额:$31.27万
-
财政年份:1994
-
负责人:Mira Edgerton
-
依托单位:
海外基金